Qin Keke, Zeng Jiale, Liu Li, Cai Yumei
School of Politics and Public Administration, Guangxi Normal University, Guilin, China.
School of Management, Jinan University, Guangzhou, China.
Front Psychiatry. 2022 Nov 9;13:990994. doi: 10.3389/fpsyt.2022.990994. eCollection 2022.
The incidence of depression is higher in PLWH (people living with HIV) than in the general population. It is of clinical significance to explore effective measures to improve depression in patients. But the available evidence is still quite limited. CBT (cognitive behavioral therapy) is considered to be one of the effective methods to improve depression, medication adherence and quality of life in PLWH. Therefore, this study aimed to systematically evaluate the effect of cognitive behavioral therapy on improving depressive symptoms and increasing adherence to antiretroviral therapy (ART) in people living with HIV (Human Immunodeficiency Virus). The Cochrane Library, Embase, PubMed, and Web of Science databases were searched by computer to collect randomized controlled trials on the effects of cognitive behavioral therapy on improving depression and increasing ART medication adherence in PLWH, and the retrieval time was from the inception of each database to January 10, 2022. Meta-analysis was performed by two researchers using Stata 15.0 software after screening the literature, extracting data and evaluating quality according to inclusion and exclusion criteria. A total of 16 studies with 1,998 patients were included. Meta-analysis results showed that CBT improved depressive symptoms in PLWH (SMD = -0.09, 95% CI [-0.13 to -0.04], < 0.001) with better long-term (<6 months) depression improvement (SMD = -0.09, 95% CI [-0.15 to -0.02], = 0.006) than short-term (0-6 months); the difference in improved ART medication adherence in the CBT group compared to the control group was not statistically significant (SMD = 0.04, 95% CI [-0.06 to 0.13], = 0.490). There may be publication bias due to incomplete inclusion of literature as only published literature was searched. Cognitive behavioral therapy is effective in improving depressive symptoms in people living with HIV, with better long-term (>6 months) results than short-term (0-6 months).
与普通人群相比,艾滋病毒感染者(PLWH)中抑郁症的发病率更高。探索改善患者抑郁症的有效措施具有临床意义。但现有证据仍然相当有限。认知行为疗法(CBT)被认为是改善艾滋病毒感染者抑郁症、药物依从性和生活质量的有效方法之一。因此,本研究旨在系统评价认知行为疗法对改善艾滋病毒感染者(人类免疫缺陷病毒)抑郁症状和提高抗逆转录病毒治疗(ART)依从性的效果。通过计算机检索Cochrane图书馆、Embase、PubMed和Web of Science数据库,收集关于认知行为疗法对改善艾滋病毒感染者抑郁症和提高ART药物依从性效果的随机对照试验,检索时间从各数据库建库至2022年1月10日。由两名研究人员按照纳入和排除标准对文献进行筛选、数据提取和质量评估后,使用Stata 15.0软件进行Meta分析。共纳入16项研究,1998例患者。Meta分析结果显示,认知行为疗法改善了艾滋病毒感染者的抑郁症状(标准化均数差[SMD]=-0.09,95%可信区间[-0.13至-0.04],P<0.001),长期(>6个月)抑郁改善效果(SMD=-0.09,95%可信区间[-0.15至-0.02],P=0.006)优于短期(0-6个月);与对照组相比,认知行为疗法组在改善ART药物依从性方面的差异无统计学意义(SMD=0.04,95%可信区间[-0.06至0.13],P=0.490)。由于仅检索了已发表的文献,可能存在文献纳入不完整导致的发表偏倚。认知行为疗法对改善艾滋病毒感染者的抑郁症状有效,长期(>6个月)效果优于短期(0-6个月)。